Grants and Contributions:
Title:
Development of Commercial Scale DispersinB® Production Method
Agreement Number:
997959
Agreement Value:
$74,490.00
Agreement Date:
Nov 15, 2022 - Jul 15, 2023
Description:
To develop a cost-effective fermentation and purification manufacturing process for DispersinB®
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Winnipeg, Manitoba, CA R3T 6G2
Reference Number:
172-2022-2023-Q3-997959
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
884326117
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Amendment Date
Mar 16, 2023
Recipient's Legal Name:
Kane Biotech Inc.
Federal Riding Name:
Winnipeg South
Federal Riding Number:
46013
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: